A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Thoracic Oncology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e31819c7dafPMID 19240650PMCID PMC3528175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mathematical Statistics

  2021cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials.

  2007cited by this paper
• Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.

  2005cited by this paper
• Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base.

  2005cited by this paper
• Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

  2005cited by this paper
• Early versus late chest radiotherapy for limited stage small cell lung cancer.

  2004cited by this paper
• Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer

  2004cited by this paper
• 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.

  2004cited by this paper
• Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.

  2004cited by this paper
• A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.

  2004cited by this paper
• Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation.

  2003cited by this paper
• Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.

  2003cited by this paper
• Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.

  2002cited by this paper
• "The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?

  2002cited by this paper
• A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.

  2001cited by this paper
• Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.

  2001cited by this paper
• Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer.

  2001cited by this paper
• Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

  2000cited by this paper
• Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

  2000cited by this paper
• Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.

  1999cited by this paper
• A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.

  1999cited by this paper
• Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.

  1999cited by this paper
• Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

  1999cited by this paper
• A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.

  1997cited by this paper
• Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

  1997cited by this paper
• A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group.

  1995cited by this paper
• Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

  1995cited by this paper
• Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

  1994cited by this paper
• In vitro studies of Taxol as a radiation sensitizer in human tumor cells.

  1994cited by this paper
• Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

  1993cited by this paper
• Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

  1993cited by this paper
• Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

  1992cited by this paper
• Taxol: a novel radiation sensitizer.

  1992cited by this paper
• A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

  1992cited by this paper
• Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

  1992cited by this paper
• Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.

  1991cited by this paper
• Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update.

  1989cited by this paper
• Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

  1988cited by this paper
• The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial.

  1988cited by this paper
• Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.

  1987cited by this paper
• VP-16 and cisplatin as first-line therapy for small-cell lung cancer.

  1985cited by this paper
• Introduction to Mathematical Statistics (4th ed.).

  1980cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Prise en charge des cancers bronchiques à petites cellules de stade localisé : actualisation

  2025cites this paper
• Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases: A case report

  2024cites this paper
• Prise en charge des cancers bronchiques à petites cellules de stade localisé i actualisation

  2024cites this paper
• Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers

  2024cites this paper
• Prise en charge des cancers bronchiques à petites cellules de stade localisé, actualisation

  2023cites this paper
• Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.

  2022cites this paper
• Thoracic radiotherapy in small cell lung cancer—a narrative review

  2021cites this paper
• Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.

  2020cites this paper
• Anti-angiogenesis treatment in a patient with appendix metastasis of small cell lung cancer

  2019cites this paper
• A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited‐stage small cell lung cancer in elderly patients versus younger patients

  2018cites this paper
• Cáncer de pulmón microcítico. Otros tumores torácicos: mesotelioma, timoma y tumores germinales mediastínicos

  2017cites this paper
• Radiothérapie des cancers bronchiques à petites cellules

  2016cites this paper
• [Radiotherapy for small cell lung carcinoma].

  2016cites this paper
• Quantitative analysis of tumor shrinkage due to chemotherapy and its implication for radiation treatment planning in limited-stage small-cell lung cancer

  2013cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: Review of Clinical Studies

  2012cites this paper
• Chemotherapy-Induced Neuropathic Pain

  2012cites this paper
• Radiation/Paclitaxel Treatment of p53-Abnormal Non-Small Cell Lung Cancer Xenograft Tumor and Associated Mechanism

  2012cites this paper
• Thoracic radiotherapy for limited stage small cell lung carcinoma.

  2012cites this paper
• Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.

  2010cites this paper